Broadfin Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-62,200
| Closed | -$5.44M | – | 46 |
|
|
2018
Q3 | $5.44M | Buy |
+62,200
| New | +$5.44M | 0.8% | 33 |
|
|
2017
Q4 | – | Sell |
-74,208
| Closed | -$8.72M | – | 45 |
|
|
2017
Q3 | $8.72M | Sell |
74,208
-106,992
| -59% | -$12.6M | 1.29% | 22 |
|
|
2017
Q2 | $14.5M | Buy |
+181,200
| New | +$14.5M | 1.76% | 17 |
|